IRIS Accounts Production v24.3.2.46 09092152 Board of Directors 1.7.23 31.12.24 31.12.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh090921522023-06-30090921522024-12-31090921522023-07-012024-12-31090921522022-06-30090921522022-07-012023-06-30090921522023-06-3009092152ns15:EnglandWales2023-07-012024-12-3109092152ns14:PoundSterling2023-07-012024-12-3109092152ns10:Director12023-07-012024-12-3109092152ns10:CompanyLimitedByGuarantee2023-07-012024-12-3109092152ns10:SmallEntities2023-07-012024-12-3109092152ns10:AuditExempt-NoAccountantsReport2023-07-012024-12-3109092152ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-12-3109092152ns10:SmallCompaniesRegimeForAccounts2023-07-012024-12-3109092152ns10:FullAccounts2023-07-012024-12-3109092152ns10:Director22023-07-012024-12-3109092152ns10:RegisteredOffice2023-07-012024-12-3109092152ns5:CurrentFinancialInstruments2024-12-3109092152ns5:CurrentFinancialInstruments2023-06-3009092152ns5:RetainedEarningsAccumulatedLosses2024-12-3109092152ns5:RetainedEarningsAccumulatedLosses2023-06-3009092152ns5:PlantMachinery2023-07-012024-12-3109092152ns5:PlantMachinery2023-06-3009092152ns5:PlantMachinery2024-12-3109092152ns5:PlantMachinery2023-06-3009092152ns5:DeferredTaxation2023-06-3009092152ns5:DeferredTaxation2023-07-012024-12-3109092152ns5:DeferredTaxation2024-12-3109092152ns5:RetainedEarningsAccumulatedLosses2023-06-3009092152ns5:RetainedEarningsAccumulatedLosses2023-07-012024-12-31
REGISTERED NUMBER: 09092152 (England and Wales)










UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024

FOR

WORKING WITH CANCER

WORKING WITH CANCER (REGISTERED NUMBER: 09092152)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


WORKING WITH CANCER

COMPANY INFORMATION
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024







DIRECTORS: B E Wilson
I S Wilson





REGISTERED OFFICE: 36 Station Road
Thames Ditton
Surrey
KT7 0NS





REGISTERED NUMBER: 09092152 (England and Wales)





ACCOUNTANTS: RJP LLP
Ground Floor
Egerton House
68 Baker Street
Weybridge
Surrey
KT13 8AL

WORKING WITH CANCER (REGISTERED NUMBER: 09092152)

BALANCE SHEET
31 DECEMBER 2024

31.12.24 30.6.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 979 496

CURRENT ASSETS
Debtors 5 20,050 19,260
Cash at bank 128,029 136,786
148,079 156,046
CREDITORS
Amounts falling due within one year 6 13,407 18,234
NET CURRENT ASSETS 134,672 137,812
TOTAL ASSETS LESS CURRENT
LIABILITIES

135,651

138,308

PROVISIONS FOR LIABILITIES 7 186 94
NET ASSETS 135,465 138,214

RESERVES
Income and expenditure account 8 135,465 138,214
135,465 138,214

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 April 2025 and were signed on its behalf by:





B E Wilson - Director


WORKING WITH CANCER (REGISTERED NUMBER: 09092152)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024


1. STATUTORY INFORMATION

Working With Cancer is a private company, limited by guarantee , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of consultancy services, excluding Value Added Tax. Turnover is
recognised in the period in which the services are provided.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Taxation
Taxation for the period comprises current. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 July 2023 1,452
Additions 810
At 31 December 2024 2,262
DEPRECIATION
At 1 July 2023 956
Charge for period 327
At 31 December 2024 1,283
NET BOOK VALUE
At 31 December 2024 979
At 30 June 2023 496

WORKING WITH CANCER (REGISTERED NUMBER: 09092152)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 30.6.23
£    £   
Trade debtors 20,050 19,260

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 30.6.23
£    £   
Tax - 1,577
Social security and other taxes 433 433
VAT 3,390 7,442
Other creditors 2,052 660
Directors' loan accounts 6,281 6,781
Accrued expenses 1,251 1,341
13,407 18,234

7. PROVISIONS FOR LIABILITIES
31.12.24 30.6.23
£    £   
Deferred tax 186 94

Deferred
tax
£   
Balance at 1 July 2023 94
Provided during period 92
Balance at 31 December 2024 186

8. RESERVES
Income
and
expenditure
account
£   

At 1 July 2023 138,214
Deficit for the period (2,749 )
At 31 December 2024 135,465

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following loan from a director subsisted during the period ended 31 December 2024 and the year ended 30 June 2023:

31.12.24 30.6.23
£    £   
Director
Balance outstanding at start of period (6,781 ) (6,781 )
Amounts advanced 709 102
Amounts repaid (209 ) (102 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of period (6,281 ) (6,781 )

WORKING WITH CANCER (REGISTERED NUMBER: 09092152)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024


9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

This amount is interest free.

10. LIMITED BY GUARANTEE

The company is a private company limited by guarantee and not having a share capital.

The company has a not for profit status with an 'asset lock' which ensures that assets are used only for the benefit of the community.